Seelos Therapeutics Inc. (NASDAQ: SEEL) open the trading on April 06, 2021, with a bit cautious approach as it glided -10.00% to $4.95. During the day, the stock rose to $5.75 and sunk to $4.95 before settling in for the price of $5.50 at the close. Taking a more long-term approach, SEEL posted a 52-week range of $0.44-$5.89.
Meanwhile, its Annual Earning per share during the time was 67.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 83.10%. This publicly-traded company’s shares outstanding now amounts to $73.25 million, simultaneously with a float of $68.10 million. The organization now has a market capitalization sitting at $356.15 million. At the time of writing, stock’s 50-day Moving Average stood at $3.56, while the 200-day Moving Average is $1.68.
Seelos Therapeutics Inc. (SEEL) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Seelos Therapeutics Inc.’s current insider ownership accounts for 7.02%, in contrast to 10.80% institutional ownership.
Seelos Therapeutics Inc. (SEEL) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2020 suggests? It has posted -$0.13 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.08) by -$0.05. This company achieved a return on equity of -1,489.36. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
Seelos Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 83.10% and is forecasted to reach -0.46 in the upcoming year.
Seelos Therapeutics Inc. (NASDAQ: SEEL) Trading Performance Indicators
Let’s observe the current performance indicators for Seelos Therapeutics Inc. (SEEL). It’s Quick Ratio in the last reported quarter now stands at 2.40. The Stock has managed to achieve an average true range (ATR) of 0.58.
In the same vein, SEEL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.43, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.46 at the market close of one year from today.
Technical Analysis of Seelos Therapeutics Inc. (SEEL)
[Seelos Therapeutics Inc., SEEL] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 78.00% While, its Average True Range was 0.61.
Raw Stochastic average of Seelos Therapeutics Inc. (SEEL) in the period of the previous 100 days is set at 81.64%, which indicates a major rise in contrast to 62.62% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 125.06% that was lower than 140.40% volatility it exhibited in the past 100-days period.